L-DOPA ABSORPTION AND METABOLISM BY HUMAN STOMACH

被引：0
|
作者：
CALIMLIM, LR
MORGAN, JP
DUJOVNE, CA
BIANCHIN.JR
LASAGNA, L
机构：
来源：
JOURNAL OF CLINICAL INVESTIGATION | 1970年 / 49卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A79 / &
相关论文
共 50 条
  • [41] METABOLISM OF L-DOPA IN PIGTAIL MONKEY - EFFECT OF A-DOPA DECARBOXYLASE INHIBITOR
    BRONAUGH, RL
    WENGER, GR
    GARVER, DL
    RUTLEDGE, CO
    PHARMACOLOGIST, 1974, 16 (02): : 236 - 236
  • [42] Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa dose
    Heikkinen, H
    Varhe, A
    Laine, T
    Puttonen, J
    Kela, M
    Kaakkola, S
    Reinikainen, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 363 - 371
  • [43] CONVERSION OF EXOGENOUSLY ADMINISTERED L-DOPA TO DOPAMINE IN STOMACH AND LIVER OF RATS
    OSUMI, Y
    WADA, I
    FUJIWARA, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 1972, 22 (05): : 723 - &
  • [44] EFFECT OF L-DOPA ON HUMAN INTRAGASTRIC PRESSURE
    VALENZUELA, JE
    EGUIGUREN, AL
    GASTROENTEROLOGY, 1976, 70 (05) : 945 - 945
  • [45] INHIBITION OF L-PHENYLALANINE ABSORPTION BY L-DOPA IN PATIENTS WITH PARKINSONISM
    GRANERUS, AK
    JAGENBURG, R
    RODJER, S
    SVANBORG, A
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1971, 137 (03): : 942 - +
  • [46] RISKS OF PARKINSONISM TREATMENT WITH L-DOPA AND L-DOPA DECARBOXYLASE INHIBITOR
    JORG, J
    MEDIZINISCHE WELT, 1979, 30 (46): : 1740 - 1742
  • [47] PRESCRIBING OF L-DOPA
    DINGLE, CJ
    MEDICAL JOURNAL OF AUSTRALIA, 1971, 1 (19) : 1034 - &
  • [48] L-DOPA AND FAVISM
    BEUTLER, E
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1970, 36 (04): : 523 - &
  • [49] METHYLDOPA AND L-DOPA
    不详
    POSTGRADUATE MEDICINE, 1970, 47 (06) : 22 - &
  • [50] CARDIOLOGIST AND L-DOPA
    DUCLOUX, G
    MOUTON, Y
    WAREMBOURG, H
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1972, 21 (06): : 545 - 553
12345